DX series
1 / 1Pages

BAIHE - ABLE ^ BAIHE - ABLE9 Treatment Sketch Plasma Bilirubin Absorption: After separated, the plasma is purified Double Plasma Molecule Absorption System (DPMAS): After separated, the by passing through DX Series bilirubin absorption column and plasma successively passes through DX Series bilirubin absorption column and subsequently return back to human body. MG hemoperfusion cartridge and subsequently return back to human body. Absorption Mechanism ndication for Use Blood Blood pump Purified blood Plasma pump Purified plasma The function of bilirubin adsorption is decided by electrostatic interaction between the negative charge of the carboxyl group of bilirnbin and the positive charge of quaternary ammonium salt of the anion exchange resin. Vitro Test Result Absorption rate in plasma (in vitro) 100% 90% DX Series bilirubin adsorption column is designed for treatment of fulminant hepatitis, post-operative liver failure, primary biliary cirrhosis, hyperbilirubinemia and Bile acid syndrome, the adsorption of bilirubin and bile acid from plasma and is an effective and safe approach for hemopurification of the patients who have hepatopathy such as fulminant hepatitis, post-surgery hepatic failure, primary biliary cirrhosis and hyperbilirubinemia. 10. | | | Vitro Test Condition: Absorption column: one pcss (1/350) Sample: plasma 2.4L (Equivalent volume) Flow rate: 20mL/min(Equivclent rate) Highly Specific Bilirubin Absorption ColumnClinical Study of Plasma Bilirubin Absorption Result of clinical studies in Shanghai Changzheng Hospital, Foshan Affiliated Hospital of Sun Yat-sen University and Guangzhou Eighth People's Hospital: There was a significant decline for every indicator after absorption treatment. Conclusion: DX350 is not inferior to Japanese control sample, it has good capability of clearing bilirubin and bile acid, the patients liver function is improved after treatment and the clinical symptom is relieved at different level, it's effective after integrated clinical evaluation. Simultaneously, it has excellent biocompatibility. Double Plasma Molecular Absorption System (DPMAS) Clinical Study Result of Clinical Study: Bilirubin level declined significantly after DPMSA treatment, there was also statistical significance in terms of inflammatory mediators clearance. The combined treatment of bilirubin absorption column and MC Series Hemoperfusion cartridge. Double Plasma Molecular Absorption enable to specifically clear bilirubin, meanwhile is capable of eliminating inflammatory mediators, relieving the inflammatory symptom, immunoreaction, and improving prognosis.